HCA Healthcare, Inc. - Q1 2003 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2003. HCA Inc. is a holding company owning and operating 173 hospitals and 74 freestanding surgery centers across 22 U.S. states, England, and Switzerland. The company operates through two primary geographic groups: Eastern and Western, plus a Corporate and other group.
Key Financial Metrics
| Metric (in millions) | Q1 2003 | Q1 2002 |
|---|---|---|
| Revenues | $5,273 | $4,873 |
| Net Income | $469 | $385 |
| Diluted EPS | $0.90 | $0.74 |
| Operating Cash Flow | $755 | $609 |
| Cash and Equivalents (End of Period) | $1,090 | $62 |
| Total Debt (Long-term + Current) | $7,715 | Filing text does not provide clear Q1 2002 total debt |
| EBITDA | $1,109 | $1,043 |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 8.2% year-over-year, driven by a 9.6% increase in revenue per equivalent admission, despite a 0.4% decline in same-facility admissions.
- Profitability: Net income rose 21.6% to $469 million. Income before taxes increased 22.1%, aided by a $74 million pretax gain on the sale of facilities and lower interest expense ($114 million vs. $121 million).
- Liquidity: Cash and cash equivalents surged from $161 million at year-end 2002 to $1,090 million, largely in anticipation of the Health Midwest acquisition.
- Volume Trends: Same-facility admissions declined 0.4% due to a light flu season, closures of skilled nursing and obstetric units, and non-renewal of managed care contracts in Houston and Tennessee. Outpatient surgeries declined 2.9%.
- Costs: Salaries and benefits increased as a percentage of revenue to 39.8% (from 39.6%) due to lower volumes. The provision for doubtful accounts rose to 8.1% of revenue.
Guidance, Outlook, Risks, and Unusual Items
- Acquisitions: HCA completed the acquisition of the Health Midwest system (11 hospitals) on April 1, 2003, for approximately $855 million in cash. Results will be consolidated starting April 1, 2003.
- Government Investigations: HCA remains subject to extensive DOJ and CMS investigations. A "DOJ Understanding" was reached in December 2002 (approved May 2003) involving a $631 million payment to resolve claims related to physician relations and cost reports. A $250 million CMS settlement was also approved. These settlements were accrued in 2002 but remain contingent on court approval.
- Charity Care Policy: HCA announced plans to expand charity care eligibility to patients with income up to 200% of the federal poverty level. Management estimates this could reduce net revenue by $325-$375 million annually if fully implemented, though it would reduce bad debt expense.
- Capital Allocation: HCA authorized a new $1.5 billion share repurchase program in April 2003. Annual capital expenditures are expected to be approximately $2.0 billion in 2003.
- Risks: Significant risks include the outcome of pending litigation (qui tam actions, shareholder suits), potential changes to Medicare outlier payments (which could reduce revenue by up to $12 million monthly), and the successful implementation of new IT systems (MARS and ERP).
Investor Verification Checklist
- Verify the final court approval status of the DOJ and CMS settlement agreements and the timing of the associated cash outflows.
- Monitor the impact of the new charity care policy on net revenue and bad debt expense in subsequent quarters.
- Assess the integration progress and financial contribution of the Health Midwest system in Q2 2003.
- Review updates on the status of the MARS (accounts receivable) and ERP system implementations, including cost overruns or delays.
- Track the status of the SEC investigation regarding anti-fraud and internal accounting controls.
- Confirm the impact of potential changes to Medicare outlier payment rules on future revenue projections.